Previous 10 | Next 10 |
2023-12-23 13:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-12-10 12:00:28 ET More on Agilent, Danaher, etc. Agilent: A Wide Moat Company Expected To Return To Growth In 2024 (Rating Upgrade) Thermo Fisher Scientific: Acquiring And Disappointing At The Same Time Thermo Fisher Scientific: Normalization Confirmed, In Searc...
Venlo, the Netherlands, and Deerfield Beach, Florida, Nov. 30, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and DNA Labs International announced today that DLI has recently solved two decades-old “cold cases” using QIAGEN solutions. The products in...
Venlo, the Netherlands, Nov. 15, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the expansion of its sample technologies portfolio with the introduction of two new products aimed at supporting researchers in managing diverse materials such as bone, tis...
Venlo, the Netherlands, Nov. 09, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of three new kits for use on its QIAcuity systems and a major new software update designed to expand the portfolio of applications for use of digital PCR technol...
Venlo, the Netherlands, Nov. 06, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the Microbiome WGS SeqSets, a comprehensive Sample to Insight workflow designed to provide an easy-to-use solution that maximizes efficiency and reproducibili...
QIAGEN and Element Biosciences partner to offer complete next-generation sequencing workflows for the AVITI System PR Newswire Partnership combines QIAGEN's QIAseq panels, CLC LightSpeed, and QCI Interpret software to support Element's AVITI System users in genomic anal...
2023-10-31 12:42:10 ET Qiagen N.V. (QGEN) Q3 2023 Results Conference Call October 31, 2023 09:00 AM ET Company Participants John Gilardi - VP, Corporate Communications & IR Thierry Bernard - CEO Roland Sackers - CFO Phoebe Loh - IR Conference Call P...
2023-10-30 16:18:34 ET More on Qiagen Qiagen: No Upsides Slated In FY'23 In Core Business Lines, Reiterate Hold Qiagen Q3 2023 Earnings Preview For further details see: Qiagen Non-GAAP EPS of $0.50 beats by $0.02, revenue of $470M misses by $0.85M
Venlo, the Netherlands, Oct. 30, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced results for the third quarter and first nine months of 2023. Net sales results of $470 million at constant exchange rates (CER) for Q3 2023 were above the outlook for at leas...
News, Short Squeeze, Breakout and More Instantly...
Qiagen N.V. Company Name:
QGEN Stock Symbol:
NYSE Market:
Venlo, the Netherlands, and Salt Lake City, Utah, May 30, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and Myriad Genetics (NASDAQ: MYGN) today announced they will develop a globally distributable kit-based test for analyzing Homologous Recombination Deficiency (HRD...
Venlo, the Netherlands, May 29, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of its QIAseq Multimodal DNA/RNA Lib Kit. The new kit enables seamless preparation of DNA and RNA libraries for next-generation sequencing (NGS), such as whole ge...
Venlo, the Netherlands, May 14, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced an updated version of its clinical decision support platform, QIAGEN Clinical Insight Interpret for NGS molecular profiling of hereditary and somatic diseases, has received ...